Tecentriq Patient Website May 8, 2018May 7, 2018 Brand: Tecentriq (atezolizumab), Intravenous Infusion Parent Company: Genentech Drug Type: Prescription Drug Category: Oncology Campaign: Post-Launch Targeting: Patients, Caregivers Patient Website: https://www.tecentriq.com/patient.html HCP Website: https://www.tecentriq.com/hcp.html Homepage Indication 1 About What Is Homepage (Mobile)